FROOZER - Cryotherapy with liqid nitrogen
FROOZER is a professional medical device designed for targeted local cryotherapy utilizing a sub-zero stream of vaporized liquid nitrogen reaching down to -160 °C.
Key Clinical Highlights:
- Rapid Analgesia & Thermal Shock: Immediate reduction of acute pain, swelling, and localized inflammation.
- 5-Step Airflow Control: Precision-regulated cryogenic stream with low LN2 consumption (3–10 kg/h).
- Touchscreen & 31 Presets: Intuitive operation with dedicated clinical protocols and custom memory.
- 30L Dewar Vessel: High-capacity mobile cylinder with lockable wheels and acoustic safety alarms.
Product photos on the website are for reference only. They may differ slightly from the actual product. Manufacturer hereby reserves the right to change design that would not disturb the principal functionality and safety requirements.
FROOZER
Sub-Zero Liquid Nitrogen Vapor System (-160 °C)
FROOZER is a specialized clinical device engineered for localized sub-zero cryotherapy. Directing a focused stream of cold nitrogen vapor reaching down to -160 °C onto the patient's skin, it elicits an immediate thermal-shock response, delivering rapid analgesic effects, anti-inflammatory action, and accelerated tissue regeneration.
- ✓ Ultra-Low Temperature: Sub-zero vapor stream down to -160 °C for deep neuro-reflexive response.
- ✓ Precise Airflow Modulation: 5-step digital airflow control for customized therapeutic intensity.
- ✓ Pre-Programmed Clinical Protocols: Color touchscreen with 31 preset indications and custom user memory.
- ✓ Continuous Clinical Workflow: Standard 30-liter Dewar vessel with rapid cylinder swap capability.
Physiological Mechanism & Clinical Efficacy
Targeted cryostimulation triggers profound biological reactions through thermal shock
Immediate Analgesia
Extreme temperature drop causes rapid thermal shock that temporarily dampens nociceptive nerve conduction velocity, providing instantaneous pain relief and triggering endogenous endorphin release.
Reactive Hyperemia
Initial intense vasoconstriction is followed by prolonged reactive vasodilation (Hunting reaction), markedly improving microcirculation, lymphatic drainage, and cellular metabolite clearance.
Reduction of Hypertonia
Significantly reduces neuromuscular spindle activity and skeletal muscle spasticity, facilitating post-traumatic rehabilitation and restoring functional range of motion.
Engineered for Safe & Intuitive Operation
Thermally Insulated Flexible Applicator
Ergonomically designed, lightweight delivery hose with directional nozzle allows precise aiming of the cryogenic stream to specific anatomical areas while protecting the operator from cold exposure.
Intuitive Touchscreen Interface
Features a vibrant, clear touchscreen with a dedicated database of 31 evidence-based medical treatment programs, plus empty slots for individualized practitioner regimens.
Acoustic & Optical Safety System
Equipped with automated sensors providing audible alarms upon low nitrogen levels in the vessel and an acoustic chime signaling the conclusion of the programmed treatment duration.
Mobile Clinical Chassis
Sturdy medical trolley base equipped with four high-durability swiveling wheels and dual-action foot brakes ensures silent, effortless transport between treatment cubicles.
Clinical Video Presentation
Watch the FROOZER liquid nitrogen system in therapeutic operation
Primary Clinical Indications
Orthopedics & Sports Medicine
- Acute musculoskeletal trauma (sprains, contusions, ligament strains, muscle tears)
- Post-operative joint rehabilitation and swelling management
- Tendinopathies, epicondylitis (tennis/golfer's elbow), Achilles tendonitis
- Overuse syndromes and post-exercise recovery protocols
Rheumatology & Neurology
- Rheumatoid arthritis (RA) and ankylosing spondylitis (AS)
- Periarticular inflammation, bursitis, and synovial inflammation
- Reduction of muscle spasticity and hypertonia during neurological rehab
- Chronic spinal pain syndromes, sciatica, and neuralgia
Technical Specifications
| Parameter | Specification |
|---|---|
| Cryogenic Agent | Liquid Nitrogen (LN2) |
| Maximum Vapor Stream Temperature | Down to -160 °C (-256 °F) |
| Airflow Intensity Levels | 5-step digital regulation |
| Nitrogen Consumption | 3 to 10 kg/h (continuous mode, depending on airflow step) |
| Cryogenic Cylinder Capacity | 30 Liters (Dewar flask with quick-coupling interface) |
| Therapeutic Programs | 31 factory clinical presets + user-definable custom slots |
| Display & User Interface | Color Touchscreen with intuitive graphic navigation |
| Safety Alarm System | Acoustic/visual low LN2 level indicator & end-of-treatment timer signal |
| Dimensions (L × W × H) | 900 × 500 × 1100 mm |
| Total Weight | Approx. 70 kg (including full cylinder) |
| Power Supply & Consumption | 230 V / 50 Hz | 500 W |
| Operating Ambient Conditions | Temperature: 10 – 35 °C | Humidity: 30 – 75% | Atmospheric Pressure: 700 – 1060 hPa |
| Mobility & Chassis | 4 medical-grade swiveling castors equipped with individual wheel locks |
Update: 29-10-2026, time 13:52
Attachments
Safety information:
Product compliance details in accordance with Product liability (GPSR)
FROOZER - Cryotherapy with liqid nitrogen
